Type 2 diabetes trials in Poland

In Poland 38 Also abroad 1200

38 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Type 2 Diabetes and Pregnancy a Single-arm Interventional Study
Where
Poznan
Age
18 years to 45 years
People
20
Run by
Poznan University of Medical Sciences
See details and how to joinNCT07602036
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Bialystok, Bydgoszcz, Cracow, Gdynia, Lublin, Opole, Tarnów, Tychy, Warsaw, Zamość
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Białystok, Bydgoszcz, Debica, Lublin, Pabianice, Poznan, Ruda Śląska, Siedlce, Warsaw, Wroclaw
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
AMBITION 1: A research study investigating how well zenagamtide lowers blood sugar and body weight compared to placebo in people with type 2 diabetes treated with diet and exercise.
Where
Katowice, Malbork, Oswiecim, Plock, Staszow, Świnoujście, Warsaw
Age
18 years and over
People
85 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525470-18-00 · EU 2026-525470-18-00
Phase 3Taking people
"AMBITION 2: A research study investigating how well zenagamtide lowers blood sugar and body weight compared to placebo in people with type 2 diabetes and chronic kidney disease treated with once daily basal insulin alone or in combination with metformin, SGLT2i, or both."
Where
Chorzów, Gdansk, Lublin, Olsztyn, Oswiecim, Swiecie, Warsaw, Zabrze
Age
18 years and over
People
95 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525471-13-00 · EU 2026-525471-13-00
Phase 3Taking people
AMBITION 3: A research study investigating how well zenagamtide at higher dose levels lowers blood sugar and body weight compared to semaglutide in people with type 2 diabetes treated with metformin, SGLT2i, or both
Where
Bialystok, Chojnice, Lublin, Piotrkow Trybunalski, Tarnów, Warsaw, Wrocław, Zabrze
Age
18 years and over
People
595 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525472-26-00 · EU 2026-525472-26-00
Phase 3Taking people
AMBITION 4: A research study investigating how well zenagamtide at lower dose levels lowers blood sugar and body weight compared to semaglutide at lower dose levels in people with type 2 diabetes treated with metformin, SGLT2i, or both
Where
Cracow, Leczna, Malbork, Skierniewice, Sosnowiec
Age
18 years and over
People
245 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525474-20-00 · EU 2026-525474-20-00
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
Gdansk, Lublin, Poznan, Wrocław, ZDROWIE OSTEO-MEDIC S.C. L. i A. Racewicz, A. i J. Supronik
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Taking people
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
Where
Bialystok, Cracow, Mazowieckie, Warsaw
Age
18 years and over
People
600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07843485 · EU 2026-526189-25-00
No phaseTaking people
Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin
Where
Bialystok
Age
18 years to 65 years
People
50
Run by
Medical University of Bialystok
See details and how to joinNCT07919236
Phase 2Taking people
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Where
Bialystok, Cracow, Gdansk, Lodz, Lublin, Tarnów, Warsaw, Warszawa, Wroclaw
Age
18 years to 75 years
People
200 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Bialystok, Bydgoszcz, Cracow, Elblag, Lodz, Lublin, Ruda Śląska, Zabrze
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Not yet taking people in Poland
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Bialystok, Białystok, Krakow, Kraków, Lublin, Piotrkow Trybunalski
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Where
Bialystok, Częstochowa, Kielce, Lodz, Lublin, Poznan, Radom, Warsaw
Age
18 years and over
People
2,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Bialystok, Cracow, Elblag, Gdynia, Katowice, Legnica, Lodz, Poznan, Radzionkow, Warsaw, Wroclaw
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Belchatow, Bialystok, Bydgoszcz, Chojnice, Cracow, Częstochowa, Elblag, Gdynia, Katowice, Lodz, Olsztyn, Opole, Staszow, Warsaw, Wroclaw
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
Bialystok, Elblag, Gdynia, Katowice, Krakow, Legnica, Lodz, Poznan, Radzionków, Warsaw, Wroclaw
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
No phaseTaking people
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
Where
Gdansk, Krakow, Kraśnik, Lublin, Nadarzyn, Warsaw
Age
18 years and over
People
270 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06704672
Phase 3Taking people
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Where
Bialystok, Cracow, Lodz, Lublin, Poznan, Radom, Warsaw
Age
18 years and over
People
1,200 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00
Phase 3Taking people
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
Where
Biała Podlaska, Bydgoszcz, Cracow, Czestochowa, Gdansk, Gdynia, Katowice, Krakow, Lodz, Łódź, Lublin, Poznan, Pulawy, Siedlce, Staszow, Torun, Warsaw, Warszawa, Wroclaw, Wrocław
Age
18 years and over
People
549 worldwide
Run by
Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526336-39-00 · EU 2026-526336-39-00
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Bialystok, Bydgoszcz, Kielce, Krakow, Lodz, Lublin, Poznan, Radom, Warsaw
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Taking people
A Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
Where
Bialystok, Cracow, Elblag, Gdynia, Katowice, Legnica, Lodz, Poznan, Radzionkow, Warsaw, Wroclaw
Age
18 years and over
People
420 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524616-11-00 · EU 2025-524616-11-00
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Where
Bialystok, Białystok, Kielce, Lublin, Oswiecim
Age
18 years to 75 years
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00
Phase 4Taking people
Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 Diabetes
Where
Zabrze
Age
35 years to 75 years
People
100
Run by
Silesian Centre for Heart Diseases
See details and how to joinNCT07852988
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Bialystok, Białystok, Bydgoszcz, Cracow, Debica, Katowice, Poznan, Rzeszow, Warsaw, Wroclaw
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00